Blake Wise
Chief Executive Officer at Novome Biotechnologies, Inc.
Net worth: - $ as of 2024-03-30
Network origin in Blake Wise first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
24
| Extinct | Pharmaceuticals: Major | 24 |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA.
6
| Holding Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Blake Wise via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INTUITIVE SURGICAL, INC. | Medical Specialties | Compliance Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Compliance Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Private Equity Investor | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Administrative Officer | |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Medical Specialties | Comptroller/Controller/Auditor | |
| AMYRIS, INC. | Chemicals: Specialty | General Counsel | |
| CASTLIGHT HEALTH, INC. | Packaged Software | Founder Chief Executive Officer | |
Myriad Women's Health, Inc.
 Myriad Women's Health, Inc. Medical/Nursing ServicesHealth Services Myriad Women's Health, Inc. provides pre-pregnancy genetic testing services. It operates as a medical technology company that gives people access to vital information about their bodies, including DNA analysis for family preparation, and inherited cancers. The firm offers genetic counseling over the phone and gives client direct access to a professional genetics expert who can interpret their report. The company was founded by Ramji Srinivasan, Eric A. Evans, Rishi Kacker and Balaji S. Srinivasan on October 24, 2007 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | General Counsel | |
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Corporate Officer/Principal | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
| Brandeis University | College/University | Undergraduate Degree | |
| Temple University (Pennsylvania) | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Keck Graduate Institute of Applied Life Sciences | College/University | Director/Board Member | |
The Aspen Institute, Inc.
 The Aspen Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Aspen Institute operates an institution that fosters leadership skills and open-minded dialogue. It conducts seminars, policy programs, conferences and leadership development initiatives, the Institute and its international partners seek to promote nonpartisan inquiry. The company was founded in 1949 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of the Witwatersrand | College/University | Doctorate Degree | |
| National Taiwan University | College/University | Undergraduate Degree | |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Medical Specialties | Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Private Equity Investor | |
BioCentury Publications, Inc.
 BioCentury Publications, Inc. Publishing: Books/MagazinesConsumer Services BioCentury Publications, Inc. publishes a bioindustry news. It provides information, analysis and data for biotechnology and pharmaceutical companies, investors, academia, and government on the strategic issues essential to the formation, development and sustainability of life science ventures worldwide. The company was founded by David Flores and Karen Bernstein in 1992 and is headquartered in Redwood City, CA. | Publishing: Books/Magazines | Founder | |
Project Open Hand, Inc.
 Project Open Hand, Inc. Services to the Health IndustryHealth Services Project Open Hand, Inc. is a nonprofit organization that provides meals to critically ill neighbors and seniors. The company was founded in 1985 and is headquartered in San Francisco, CA. | Services to the Health Industry | Director/Board Member | |
| Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | ||
| Haas School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Columbia Law School | College/University | Graduate Degree | |
| Glaxo Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sano Intelligence, Inc.
 Sano Intelligence, Inc. BiotechnologyHealth Technology Sano Intelligence, Inc. develops wearable sensor platform for the continuous detection and wireless transmission of metabolic data. It provides easyaccess to check current glucose levels and historical trends to turn insight into action. The company was founded by Ashwin Meher Pushpala and Raj Gokal in 2011 and is headquartered in San Francisco, CA. | Biotechnology | General Counsel | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | General Counsel Corporate Officer/Principal | |
Mammoth Biosciences, Inc.
 Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA. | Internet Software/Services | General Counsel | |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Federation Bio, Inc. uses microbiome therapeutics to address medical needs. The company was founded by Racquel N. Bracken, Michael Fischbach and Dylan Dodd and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Founder | |
| INVIVYD, INC. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Altrubio, Inc.
 Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Internet Retail | Director/Board Member | |
Kelonia Therapeutics, Inc.
 Kelonia Therapeutics, Inc. BiotechnologyHealth Technology Kelonia Therapeutics, Inc. is a company based in Cambridge, MA that is pioneering a new wave of genetic medicines using its in vivo gene placement system (iGPS™). The company's simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. Initially focused on developing transformational in vivo CAR T therapies for hematologic cancers, Kelonia Therapeutics is building a pipeline of genetic medicines for a range of diseases, with the bold goal of making genetic medicines accessible to every patient in need, when and where they need them. The company was founded by Michael Fischbach, Michael Birnbaum. | Biotechnology | Director/Board Member Founder |
Statistics
International
| United States | 48 |
| Switzerland | 2 |
| South Africa | 2 |
| Taiwan | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 14 |
| Commercial Services | 3 |
| Technology Services | 3 |
| Health Services | 3 |
Operational
| Director/Board Member | 148 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 36 |
| Undergraduate Degree | 22 |
| Director of Finance/CFO | 20 |
Most connected contacts
| Insiders | |
|---|---|
| Daniel Janney | 47 |
| Bryan Roberts | 44 |
| Alan Colowick | 27 |
| Kiersten Stead | 20 |
| Halley Gilbert | 17 |
| Zachary Hornby | 15 |
| David N. Cook | 13 |
| Michael Fischbach | 12 |
| Gary Loeb | 11 |
| Derek A. Bertocci | 10 |
| John C. Doyle | 10 |
| Kenneth Hillan | 10 |
| Karen Bernstein | 9 |
| Elizabeth Bhatt | 9 |
| Janet Dorling | 8 |
- Stock Market
- Insiders
- Blake Wise
- Company connections
